- Report
- August 2023
- 1300 Pages
Global
From €7863EUR$8,900USD£6,857GBP
- Report
- October 2025
- 94 Pages
India
From €4285EUR$4,850USD£3,736GBP
- Report
- June 2025
- 81 Pages
From €3048EUR$3,450USD£2,658GBP
- Report
- June 2025
- 77 Pages
Japan
From €2165EUR$2,450USD£1,887GBP
- Report
- June 2020
- 464 Pages
Global
From €4329EUR$4,900USD£3,775GBP
- Book
- November 2023
- 200 Pages

The Genomic Medicine market is a rapidly growing sector of the genomics industry. It focuses on the development and application of genomic technologies to improve healthcare outcomes. This includes the use of genomic sequencing to diagnose and treat diseases, as well as the development of personalized treatments based on a patient's genetic profile. Genomic Medicine also involves the use of bioinformatics to analyze and interpret genomic data, and the development of new technologies to enable the use of genomic data in clinical practice.
The Genomic Medicine market is driven by the increasing availability of genomic data, advances in sequencing technologies, and the growing demand for personalized healthcare. It is expected to continue to grow in the coming years, as more healthcare providers adopt genomic technologies and the use of genomic data becomes more widespread.
Some companies in the Genomic Medicine market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more